Introduction
Cationic polymers such as polyethylenimine (PEI) 1,2 and polyamidoamine dendrimers 3, 4 form complexes with pDNA (polyplexes) that are regarded as some of the most effective nonviral gene delivery systems. 5 These polymers are synthetic and not biocompatible and a rough correlation between toxicity and efficiency has been suggested for PEI. 6 In particular, several recent studies have addressed concerns about the toxicity of conventional PEI, [7] [8] [9] although PEIs of decreased molecular weights and degree of branching seem to have a reduced toxicity. 10, 11 Therefore, the search for alternative biocompatible cationic polymers that form efficient and nontoxic polyplexes is motivated.
Chitosans, a family of linear binary polysaccharides comprised of beta (1-4) linked 2-amino-2-deoxy-b-Dglucose (GlcN; D-unit) and the N-acetylated analogue (GlcNAc; A-unit), have been proposed as biocompatible alternative cationic polymers, suitable for nonviral gene delivery. Previous studies have shown that chitosan polyplexes exhibit low cytotoxicity [12] [13] [14] [15] and are suitable for gene delivery to mucosal tissues such as the intestine and the lung in vivo. 12, [16] [17] [18] [19] [20] [21] In most of these studies, commercially available chitosans of high molecular weights (100-400 kDa) were used. These chitosans form extremely stable polyplexes with DNA, which delays the release of the pDNA, and the physical shape of the polyplexes is dominated by aggregates. 12, 17, 20 Other pharmaceutical drawbacks with high-molecular-weight chitosans include their low solubility at physiological pH 22 and their viscosity enhancing properties at concentrations suitable for in vivo gene therapy. 12 We speculated that these drawbacks could be eliminated if chitosans of lower molecular weights were used, that is, chitosans that were long enough to form stable polyplexes, but sufficiently short to be soluble at neutral pH, give a reduced viscosity, form less aggregated shapes more typical for multivalent ions, and form more easily dissociated polyplexes. 23, 24 Chitosan oligomers shorter than 14 monomer units were recently found to fulfill many of these pharmaceutical requirements, but formed only weak complexes with DNA, resulting in physically unstable polyplexes that transfected cells at low efficiencies in vitro and in vivo. 20 A larger chitosan oligomer fraction (approximately a 24-mer; 4.7 kDa) formed physically stable polyplexes of comparable efficiency to very stable polyplexes based on higher molecular weights of the chitosan. We therefore hypothesized that chitosan oligomers with chain lengths intermediate to those that form unstable (p14-mers) and more stable polyplexes (X24-mers), that is, oligomers around 18-20 monomer units, would give the best possible chitosans for nonviral gene delivery. Furthermore, since there seems to be a strong dependence between the chitosan oligomer length and the properties of the polyplexes, we also wanted to study more homogeneous chitosan oligomers.
For this purpose, we first produced a low-molecularweight chitosan by random depolymerization, with a number average degree of polymerization (DPn) of 18 monomer units (DPn18), and with a well-defined distribution of the oligomers. Initial characterizations were performed of polyplexes based on DPn18 and chitosans of smaller and larger sizes to establish structure-property relationships with regard to polyplex formation and in vivo efficiency after lung administration to mice. In a second step, we isolated the chitosan oligomers from the broader DPn18 fraction to obtain fractions, ranging from 10-to 50-mers, of more homogeneous size distributions. Polyplexes of these welldefined chitosan fractions were then investigated with regard to physical-chemical properties as well as the transfection efficiency in vitro and after lung administration to mice in vivo.
Results

Structure-property relationships
A low-molecular-weight chitosan with a number average DPn of 18 (denoted as DPn18) was fractionated and found to be comprised of oligomers ranging from 6-to 50-mers ( Figure 1a) . Thus, the DPn18 chitosan contains a mixture of shorter and longer oligomers that form physically unstable (DPp14) and stable (DPX24) polyplexes, respectively. 20 We first studied the stability of polyplexes between DPn18 and pDNA at increasing charge ratios (10:1-60:1 (+/À)) in the agarose gel retardation assay. A very high charge ratio of 60:1 (+/À) was required to form polyplexes that were sufficiently stable to retain completely the pDNA in the agarose gels (Figure 1b) . The transfection efficiency of these polyplexes was tested in the 293 cell line since our previous studies have shown that there is a good qualitative relationship between the transfection efficiency in these cells and that in the mouse lung epithelium in vivo after intratracheal administration. 12, 20 As expected, the physically stable polyplexes at charge ratio 60:1 (+/À) mediated higher luciferase gene expression in 293 cells in vitro than those that separated in the gel assay. Thus, a 100-fold higher in vitro transgene expression was obtained at charge ratio 60:1 (+/À) than at 10:1 (+/À) ( Figure 1c) .
The in vivo efficiency of the DPn18 chitosan was studied after intratracheal administration to mouse lungs. 12 First, the effect of the charge ratio of DPn18 polyplexes on the level of gene expression was studied at three different charge ratios, at 10:1 (+/À) where unstable polyplexes were formed, at 30:1 (+/À) where the complexes were partially stable during agarose gel electrophoresis, and at 60:1 (+/À) where the pDNA was completely retained in the agarose gel retardation assay, c.f. Figure 1b . The luciferase gene expression was analysed 72 h after administration since previous studies using chitosan polyplexes showed peak expression at this time point. 12 The luciferase gene expression in mouse lungs increased with increasing stability of the polyplexes. Consistent with the in vitro results, the stable polyplexes at charge ratio 60:1 (+/À) mediated a fourfold higher gene expression in comparison to the less stable polyplexes at 10:1 (+/À) (Po0.001) (Figure 2a ). In vitro characterization of polyplexes based on low-molecularweight chitosan. (a) A low-molecular-weight chitosan with a number average DPn18 was fractionated with size-exclusion chromatography and found to be comprised of oligomers between 6-and 50-mers. (b) The DPn18 chitosan was complexed with 100 ng pDNA at increasing charge ratios (10:1À60:1 (+/À)) and tested for physical stability in the agarose gel retardation assay. A representative gel from three independent experiments is shown. (c) The DPn18 polyplexes were also incubated with 293 cells and the luciferase gene expression was investigated after 48 h. Physically stable polyplexes at charge ratio of 60:1 (7) mediated higher gene expression than the less stable polyplexes obtained at lower charge ratios. Results are expressed as mean values7s.d. (n ¼ 4). Statistical differences are denoted as *Po0.05, **Po0.01 and ***Po0.001, respectively.
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Notably, the gene expression obtained with less stable DPn18 polyplexes at charge ratio 10:1 (+/À) was comparable to that obtained previously with an optimized composition of ultrapure (high-molecular-weight) chitosan (UPC).
12
Dose titration studies at charge ratio 60:1 (+/À) showed that the efficiency of the polyplexes increased with an increase in the dose, from 45713 pg luciferase/ mg of total lung protein at a dose of 5 mg pDNA to 3407177 pg luciferase/mg of total lung protein at 25 mg pDNA, or seven-fold (Po0.01) (Figure 2b ). Histological observations of lung sections from mice given DPn18 polyplexes (25 mg pDNA; 60:1 (+/À)) showed no signs of immune cell infiltration in the bronchiolar epithelium or the alveolar regions (Figure 2c) . Similarly, no acute inflammatory response to the single administration of PEI polyplexes was observed (data not shown). Based on these results, we compared the in vivo efficiency of polyplexes (containing 25 mg pDNA) of different chitosan oligomers that were both shorter and longer than DPn18, at a fixed charge ratio of 60:1 (+/À) ( Figure 2d ). Polyplexes based on DPn18 mediated a four-fold higher gene expression than those based on a slightly larger chitosan fraction, DPn25 (Po0.05), and a 50-to 100-fold higher gene expression than those based on 12-and 6-mer chitosan (Po0.001) (which formed unstable polyplexes even at a charge ratio of 60:1 (+/À) of comparable efficiency to naked pDNA), supporting the hypothesis that the optimal size range for the formation of efficient chitosan polyplexes was in the vicinity of 20 monomer units.
Polyplexes based on high-molecular-weight chitosans are known to be extremely stable against decomplexation with other anionic molecules such as heparin 17 and were even found to resist high salt and detergent concentrations. 12 The high stability was suggested to be a major rate limiting step for the intracellular release of pDNA from these polyplexes, 17 and kinetic studies using transmission electron microscopy showed that chitosan polyplexes remained in intact endosomes for 424 h. 12 Since shorter oligomers (DPo14) show a weaker binding with DNA, 20 we speculated that polyplexes of DPn18 would release pDNA more easily than polyplexes of high-molecular-weight chitosan. We therefore investigated the stability of pDNA polyplexes of DPn18 with those of high-molecular-weight UPC (having a DP of around 1000) in the presence and absence of heparin. The polyplexes of the high-molecular-weight chitosan remained stable, while polyplexes of DPn18 dissociated and released the pDNA upon incubation with heparin ( Figure 3a) . Also, the plasmid remained almost completely supercoiled after dissociation from the low-molecular-weight chitosan, indicating that the complexation procedure with DPn18 did not alter the physical integrity of the plasmid (Figure 3a) . The efficiencies of these two chitosan systems were then compared in three different cell lines, that is, kidney epithelial 293 cells, airway epithelial Calu-3 cells and in cervix epithelial HeLa cells. An early time point, 48 h, was chosen since we hypothesized that the difference in the release pattern of pDNA would impact early gene expression levels. A four-to 24-fold higher gene expression was detected with the low-molecular-weight chitosan DPn18 than with the very stable polyplexes formed with high-molecular-weight chitosan (Po0.05) (Figure 3b) .
In summary, the low-molecular-weight chitosan DPn18 (that contains oligomers between 6-and 50-mers) formed physically stable polyplexes at high charge ratios (+/À) with pDNA, but where more easily dissociated and of higher efficiency than conventional high-molecular-weight chitosans. We reasoned that a fractionation of more monodisperse fractions of DPn18 would further improve the efficiency of the oligomer-based polyplexes, and give polyplexes of better defined physicochemical properties. Therefore, narrower sized chitosan oligomer fractions were purified from the DPn18 fraction for further investigations.
Characterization of chitosan polyplexes based on oligomers with narrow size distributions
In order to obtain better defined chitosan oligomers, DPn18 was separated into four fractions using sizeexclusion chromatography 25 ( Figures 1a and 4a ). The fractions were defined according to their DPn as DP10-14, DP15-21, DP22-35 and DP36-50. Chitosans shorter than 10 monomer units were excluded since they formed unstable polyplexes of low in vivo efficiency (Figure 2d ). Based on the initial studies, polyplexes of the different fractions were formed at a charge ratio of 60:1 (+/À) and properties such as the physical stability, size, morphology and the in vitro and in vivo efficiencies were compared to those of DPn18. For transfection studies in vitro and after lung administration in vivo, PEI polyplexes (25 kDa) at a previously optimized charge ratio of 5:1 (+/À) 2, 12 were used as controls.
Physicochemical characterization. All the chitosan fractions formed colloidal particles of comparable surface charge (zeta potentials ranging from 29.571.1 to 32.671.0 mV) when mixed with pDNA at a charge ratio of 60:1 (+/À) ( Table 1) . However, only fractions that contain chitosan oligomers with chain lengths longer than 22 monomer units, that is, DP22-35 and DP36-50, formed physically stable polyplexes in the agarose gel retardation assay ( Figure 4b ). As shown in Figure 4c , all the chitosan fractions formed nonaggregated polyplexes of rod-like, toroidal and spherical shapes when visualized by atomic force microscopy. The three different morphologies are apparent at larger magnifications, Figure 5 . The distribution between the three shapes depended on the chitosan fraction ( Table 1) . The oligomer fractions DP15-21 and DP22-35 formed slightly, but significantly, higher proportions of spheres compared to the polydisperse DPn18 oligomer (Po0.05). At higher pDNA concentrations (250 mg/ml), similar to those used for in vivo studies, the size of the DPn18 and DP15-21 polyplexes differed significantly: 25476 and 45713 nm, for DPn18 and DP15-21 polyplexes, respectively (Po0.001) ( Table 2 ). This suggests that DP15-21 polyplexes are more stable towards aggregation at higher concentrations than those of DPn18, and are therefore pharmaceutically more desirable.
In vitro gene expression and toxicity studies. The in vitro transfection efficiencies of chitosan oligomer and PEI polyplexes were studied in the 293 cell line ( Figure  6 ). In general, physically stable polyplexes of DPn18 and DP36-50 gave the highest luciferase gene expression of the chitosan oligomers. A clear dependence of the pH of A more rapid onset and higher gene expression were obtained with chitosan oligomer polyplexes when the transfection studies were performed at pH 5.0 compared to pH 7.4. However, in contrast to the chitosan oligomers, a lower level and a slower onset of gene expression were obtained with PEI polyplexes at pH 5.0. At pH 5.0, both DPn18 and DP36-50 showed the maximum expression at 72 h compared to 120 h at pH 7.4 (Figure 6b ). At this time point, chitosan polyplexes mediated a four-fold higher luciferase gene expression compared to PEI polyplexes (Figure 6c ), corresponding to 0.2% of the total cell protein (E2000 pg luciferase/mg of total cell protein).
Interestingly, the higher in vitro efficiency of the oligomer polyplexes at pH 5 related to a more compact polyplex structure, similar to PEI, as indicated by reduced intercalation of ethidium bromide with pDNA when the pH of the final agarose gel electrophoresis buffer was reduced (Figure 6d ). This agrees with previously reported data on chitosan oligomer-based DNA complexes using a different technique, that is, video-enhanced fluorescence microscopy. 20 No acute in vitro toxicity of the polyplexes was observed with the MTT assay (which measures the intracellular dehydrogenase activity) at concentrations used for the transfection studies (0.33 mg pDNA, corresponding to 235 mg/ml chitosan oligomer and 4.5 mg/ml PEI). However, in contrast to the low-molecular-weight chitosans, PEI showed a dose-dependent toxicity at concentrations above 20 mg/ml, giving IC 50 values of 81 and 108 mg/ml at pH 7.4 and 5.0, respectively, supporting the notion that this polymer has a dosedependent toxicity. 12, 26 Chitosan oligomers showed no toxicity at pH 5.0 or pH 7.4 even at concentrations as high as 2.5 mg/ml.
Intratracheal administration to mouse lungs. The in vivo efficiencies of the oligomeric chitosans were studied at 72 h after intratracheal administration to mouse lungs. 12 As controls, PEI and a chitosan fraction with 25 as the number average DPn (DPn25) were used.
The highest luciferase gene expression was obtained with the fraction containing 15-21 chitosan monomer units (Po0.05) (Figure 7 ). This was surprising since these polyplexes were physically unstable in the agarose gel retardation assay (c.f. Figure 4b ) and mediated low gene expression in vitro (c.f. Figure 6c) . The higher efficiency of the fraction DP15-21 was also in contrast to the finding that the in vivo efficiency of DPn18 polyplexes increased with increasing physical stability of the polyplexes, c.f. Figure 2a . DPn18 gave a lower luciferase gene expression than DP15-21, comparable to PEI (but a three-to fourfold higher expression than DPn25).
Stability of pDNA against degradation by DNase. Since the commonly accepted relationship between physical stability and efficiency was violated by DP15-21, we investigated if the physically unstable, but efficient polyplexes may have retained their capacity to protect pDNA against DNase degradation. Naked pDNA, used as control, was completely degraded upon incubation with DNase ( Figure 8a ). In contrast, for DPn18 polyplexes, both physical stability and stability against degradation by DNase increased with increasing charge ratio (Figure 8a ). This agrees with the observed increase in efficiency with an increased charge ratio of these polyplexes in vivo (Figure 2a) . Interestingly, polyplexes of DP15-21 at charge ratio 60:1 (+/À) that were classified as physically unstable in the agarose gel retardation assay also protected pDNA against degradation by DNase (Figure 8b ). This suggests that protection against degradation by DNase is also dependent on the amount of chitosan and/or the charge of the polyplexes.
In an attempt to investigate whether the DP15-21 oligomers themselves have any inhibitory effects on the DNase activity, we dissociated the DP15-21 polyplexes with heparin before incubating the decomplexed polyplexes with DNase. However, no conclusions could be drawn since the presence of heparin inhibited the DNase activity (data not shown), which is in agreement with a previous report. 27 Nevertheless, preliminary purification studies using ultrafiltration showed that the removal of excess unbound DP15-21 oligomers from the DP15-21 polyplex solution (around 60-70% of the total amount of oligomers) at the charge ratio 60:1 (+/À) drastically reduced the protection of pDNA against DNase degradation (Figure 8c) , and resulted in a four-fold lower lung gene expression (data not shown).
Kinetics and location of luciferase gene expression in mouse lungs. Polyplexes based on low-molecularweight chitosan released pDNA after incubation with heparin, in contrast to those based on high-molecularweight chitosan (Figure 3a) . We hypothesized that polyplexes that are more easily dissociated would show peak expression, C max , after lung administration at earlier time In vivo efficiency of polyplexes based on fractionated chitosan oligomers after intratracheal administration to mouse lungs. Polyplexes of the different oligomer fractions (DP10-14, DP15-21, DP22-35, DP36-50, DPn18 and DPn25) were formed at charge ratio 60:1 (7) and a dose of 25 mg pDNA. PEI polyplexes at a previously optimized charge ratio of 5:1 (7) 2,12 were used as controls. The luciferase gene expression in mouse lungs was analysed 72 h after administration. Results are expressed as mean values7s.d. (n ¼ 4-6). *Po0.05, **Po0.01 and NS ¼ no significant difference (P40.05).
Chitosan oligomers as nonviral gene delivery systems M Köping-Höggård et al points than the 72 h observed previously. 12 Indeed, the luciferase gene expression peaked already at 24 h after the administration of DPn18 and DP15-21 polyplexes, expressing 695798 and 13647285 pg luciferase/mg of total lung protein, respectively, at 24 h compared to 3517125 and 8607374 pg luciferase/mg of total lung protein, respectively, at 72 h. The DP15-21 polyplexes were as efficient as PEI polyplexes, based on AUC (area under the curve) calculations of the luciferase gene expression profile 0-72 h (Table 3) .
We also compared the distribution of the polyplexes of DPn18, DP15-21 and PEI, 24 h after administration. To localize the distribution of gene expression in mouse lungs after intratracheal administration, the luciferase gene expression was analysed in the trachea, bronchial tree and parenchyma. Independent of the delivery system, 490% of the luciferase gene expression was located in the bronchial tree ( Figure 9 ). In this part of the lung, PEI polyplexes mediated a two-fold higher gene expression than DP15-21 polyplexes (Po0.05) and a four-fold higher gene expression than DPn18 polyplexes (Po0.01), 24 h after administration.
Discussion
We developed more efficient chitosan-based gene delivery systems with improved physical properties by using narrow size-distributed chitosan oligomers as complexing agents of plasmid DNA. The size range of the chitosan oligomers was selected from a previous study that identified chitosan polyplexes based on oligomers of around 20 monomer units as promising gene delivery systems. 20 Indeed, our preliminary in vivo studies after lung administration to mouse showed a maximal efficiency with polyplexes of a number average chain length of 18 (DPn18) (Figure 2d) .
We found that a charge ratio as high as 60:1 (+/À) was required for the formation of physically stable polyplexes between the polydisperse DPn18 and pDNA that efficiently transfected cells in vitro and after lung administration in vivo. The high charge excess agrees with a recently reported charge ratio of 67:1 (+/À) for optimized polyplexes of low-molecular-weight PEI. 10, 11, 28 The necessity of such an excess of positive charges for the low-molecular-weight oligomers, in comparison to charge ratios p5:1 (+/À) used for high-molecular-weight e PEI polyplexes were used at an optimized charge ratio of 5:1 (7) 2,12
and data presented are mean values of data obtained in this study and data obtained from Kö ping-Hö ggård et al.
12 Figure 9 Location of luciferase gene expression in mouse lungs after intratracheal administration of chitosan oligomer polyplexes. Polyplexes of DP15-21 and DPn18 were formed at charge ratio 60:1 (7) and a dose of 10 mg pDNA. PEI polyplexes at charge ratio 5:1(7) were used as control. At 24 h after intratracheal administration, lung tissues were dissected into parenchyma, bronchial tree and trachea, and the luciferase gene expression in the different parts was determined. Results are expressed as mean values7s.d. (n ¼ 4-6). Statistical differences are denoted as *Po0.05 and **Po0.01, respectively. See also Table 3 for the comparison of efficiency during the 0-72 h time interval (expressed as AUC).
Chitosan oligomers as nonviral gene delivery systems M Köping-Höggård et al counterparts, 12, 17, 29 can partly be explained by the lower efficiency of shorter chain polycations to complex with the negatively charged phosphate groups of DNA. 20, 30, 31 Furthermore, the DPn18 oligomer is polydisperse (6-50 mers) and contains oligomers of chain lengths that form both physically unstable and stable polyplexes. 20 This suggests that the charge ratio of this mixture of chitosan oligomers should be regarded as an apparent charge ratio and that a free fraction of chitosan oligomers is present in the polyplex solutions. In fact, preliminary purification studies indicate that 60-70% of the chitosan oligomers were unbound in the chitosan polyplex solutions (Issa et al, unpublished results) .
The high excess of low-molecular-weight chitosan in the polyplexes may imply an increased toxicity of the delivery system. However, in agreement with polyplexes of low-molecular-weight PEI at a charge ratio of 67:1 (+/À), 11 no acute toxicity of chitosan oligomer polyplexes at charge ratio 60:1 (+/À) could be detected in the MTT assay in vitro. Furthermore, histological investigations of the mouse lung showed no structural damage or immune cell infiltration. This is in agreement with previous studies, which showed that the intratracheal administration of PEI polyplexes at a charge ratio of 5:1 (+/À) did not result in an inflammatory response, while higher charge ratios did. 32 We therefore conclude that the toxicity of the oligomers is not an issue in the present study.
In order to obtain better defined oligomer polyplexes, we separated the DPn18 oligomer into more narrow sized fractions, that is, DP10-14, DP15-21, DP22-35 and DP36-50.
In agreement with previous findings, polyplexes that were physically stable in the agarose gel retardation assay mediated higher gene expression in 293 cells in vitro compared to those that separated in the gel assay. 5, 10, 12, 13, 20, 33 However, in contrast to the qualitative relationship obtained previously between the transfection efficiency in vitro in 293 cells and in vivo in mouse lung, 12, 20 no clear relationship between the in vitro and in vivo efficiency was obtained with the chitosan oligomers in the present study.
The most likely reason for the discrepancy between the in vitro and in vivo efficiency of the less stable DP15-21 polyplexes may be that in vitro transfection actually requires relatively more stable polyplexes for efficient presentation to the cell surface in comparison to the in vivo situation where the more concentrated polyplex suspension is delivered directly to the epithelial lining of the airways. This is in agreement with the reported molecular-weight-dependent efficiency of PEI in vitro and in vivo, where more stable polyplexes of higher molecular weights are preferred in vitro, 34 but a lower molecular weight in vivo. 4, 35 Obviously, the high in vivo efficiency of the DP15-21 polyplexes has to be explained by factors other than the physical stability in the gel assay. Thus, we tested the hypothesis that the in vivo efficiency was directly related to the ability of the chitosan to protect pDNA against degradation by DNase. The impact of protecting DNA against degradation by extracellular DNase present in the lung fluid, on the efficiency of gene expression after intratracheal administration, was recently found to increase the efficiency of naked DNA 50-to 80-fold. 36, 37 We therefore studied the stability of DPn18 and DP15-21 polyplexes against DNase at a DNase concentration (1.0 U) corresponding to those found in the mouse lung (o0.6 U). 36 Indeed, our finding that the luciferase gene expression in mouse lung increased with increasing stability of polyplexes against degradation by DNase (Figures 2a and 8a) , confirmed that DNA degradation by DNase is a major barrier to efficient in vivo gene expression in the lung, and indicated that chitosan oligomers provided complete protection against this degradation at the optimal charge ratio 60:1 (+/À). Interestingly, we found a decreased protection against DNase when the excess of unbound chitosan oligomers in the DP15-21 polyplex solution was removed, suggesting that the protection against DNase degradation depends more on the amount of chitosan and/or the charge of the polyplexes than the physical stability as determined by the gel retardation assay.
Both our in vitro and in vivo transfection data support the hypothesis that dissociation of the oligomer polyplexes is a faster process for the intracellular release of pDNA from the polyplexes and the subsequent onset of action compared to a biodegradation-dependent release. First, the weaker binding of the chitosan oligomers to pDNA resulted in dissociation of the polyplexes and release of pDNA upon incubation with anionic heparin (Figure 3a) . This is in sharp contrast to the behaviour of chitosan polyplexes of higher molecular weights, which only release pDNA after enzymatic degradation of the high-molecular-weight chitosan into shorter oligomers by chitosanase. 12, 33 Therefore, the high polyplex stability shown by high-molecular-weight chitosans has been concluded to be a major rate limiting step for the intracellular release of pDNA from these polyplexes, leading to a later onset of gene expression. 12, 17 Second, the in vivo luciferase gene expression reached a C max of around 700 and 1500 pg/mg of total lung protein already at 24 h after the intratracheal administration of DPn18 and DP15-21 polyplexes to the mouse lung, respectively. This is 120-and 260-fold higher than the values previously reported for high-molecular-weight chitosan at this early time point. 12 Overall, the oligomer polyplexes in this study showed a 10-to 20-fold higher in vivo efficiency than high-molecular-weight chitosan reported previously (Table 3 ). 12 The relationship between chitosan polyplex formulation, DNase protection and release of pDNA on the in vivo efficiency of chitosan-based pDNA complexes after lung administration is schematically summarized in Figure 10 .
From the molecular weight of the chitosans, it can be calculated (using Huggins equation 38 ) that the lowmolecular-weight chitosans used in this study display a 10-fold reduced viscosity compared to the high-molecular-weight UPC at concentrations used for in vivo studies. A further improvement of oligomer-based polyplexes compared to those based on higher molecular weights is expected when these delivery systems are administrated as aerosols. The 10-fold lower viscosity of the concentrated polyplex solutions of the oligomers compared to higher molecular weight counterparts results in a more preferable size range of the generated aerosol droplets (Kö ping-Hö ggård et al, unpublished results).
The importance of dissociation of the oligomer polyplexes for the release of pDNA, compared to degradation, finds further support in the fact that the Chitosan oligomers as nonviral gene delivery systems M Köping-Höggård et al enzymatic degradation rate of chitosan by lysozyme is highly dependent on the degree of acetylation (D A ) as this rate increases proportionally to D A in the fourth power. 39, 40 Since the chitosan oligomers in the present study are fully deacetylated (D A o0.001) the degradation rate is negligible, which strongly agrees with our proposal that dissociation is more important than degradation for the release of pDNA from these complexes. Indeed, using the assumptions applied by Zabner et al, 41 we calculated that complete dissociation of the oligomer polyplexes would increase the endosomal osmolarity to 4 M, which is far above that required for endosomal rupture and release of the endosomal cargo into the cytoplasm.
In conclusion, polyplexes based on well-defined and narrow size-distributed chitosan oligomers fulfill many of the requirements of an efficient gene delivery system to the lung tissue. Their superior efficiency in comparison to conventional high-molecular-weight chitosanbased polyplexes is a result of their weaker association with pDNA and the retained capacity of the chitosan oligomers to protect pDNA against DNase degradation, which enables an efficient release and delivery of the intact transgene. The results of this study forward oligomeric chitosans as biocompatible nonviral gene delivery systems and present a platform for further optimization studies of chitosan-based gene delivery systems, for example, with regard to steric stabilization and targeting.
Materials and methods
Materials
A plasmid (gWiz TM Luc) of GMP grade containing a cytomegalovirus promoter (CMV) and a firefly luciferase reporter gene (pCMV-Luc) was purchased from Aldevron, Fargo, ND, USA. UPC, Protasan UPG 210, batch number 902-572-05, was obtained from Pronova Biopolymer, Oslo, Norway. PEI (25 kDa) was obtained from Aldrich Sweden, Stockholm, Sweden.
Cells
The human embryonic kidney epithelial cell line 293 and the human cervix epithelial cell line HeLa were obtained from ATCC, Rockville, MD, USA, and the human airway epithelial cell line Calu-3 was a kind gift from Dr Ursula Hultkvist-Bengtsson, AstraZeneca R&D Lund, Sweden. The cells were regularly assayed and found to be free from mycoplasm infections and were maintained according to the supplier's recommendations.
Preparation and characterization of chitosan oligomers
A fully deacetylated chitosan (F A o0.001) was depolymerized with nitrous acid 42 to obtain samples with number average DPn of 25 and 18, respectively, as determined by 13 C-NMR. 43 The DPn18 sample was subsequently fractionated by Superdex 30 gel filtration as described previously, 25 and fractions corresponding to DP intervals of 10-14, 15-21, 22-35 and 36-50 were pooled ( Figure 1a) . The chain length distributions were analysed by size-exclusion chromatography with a multiangle laser light scattering detector (SEC-MALLS). The results are summarized in Table 4 . The results demonstrated that the Superdex fractions had number (DPn) and weight average (DPw) degrees of polymerization (residues per chain) that were very close to those calculated for the corresponding subpopulations (DP intervals) of a Kuhn distribution with DPn ¼ 25. The experimentally determined polydispersities were slightly higher than the theoretical values, which we attributed to some peak overlap with oligomers eluting just before and after the peaks selected for analysis. We also note that 13 C-NMR gave lower DPn values than SEC-MALLS, probably reflecting the difficulty of accurately determining the area of minor NMR signals. The good agreement between theoretical and experimental DP values obtained by SEC-MALLS adds credibility to this method.
Fractionated, monodisperse 6-and 12-mer chitosans (denoted as DP6 and DP12, respectively) were obtained as described previously. 20 
Formulation of polyplexes
Chitosan stock solutions (2 mg/ml) were prepared by dissolving chitosan in sterile deionized MilliQ water, pH 6.270.1, and then filtering the solutions under sterile conditions. Chitosan polyplexes were formulated by adding chitosan and then pDNA stock solutions to the solvent under intense stirring on a vortex mixer (Heidolph REAX 2000, level 4, Kebo Lab, Spånga, Sweden). The following amounts of the different chitosans were used per mg pDNA to prepare chitosan polyplexes at a charge ratio of 1:1 (+/À):0.60 mg of DP10-14, DP15-21, DP22-35, DP36-50, DPn18 and DPn25 as chloride salts, 0.68 mg of DP6 and DP12 as acetate salts and 1.05 mg of UPC as glutamate salts. The charge ratio was defined as the ratio between the maximum number of protonable primary amines in chitosan and the number of negative phosphates on pDNA. 44 For in vitro studies (ie gel retardation and stability assays, analysis of particle size and morphology, and transfection experiments), different charge ratios of Figure 10 A schematic contour plot presentation of the relationship between chitosan polyplex formulation, DNase protection and release of pDNA on the in vivo efficiency of chitosan-based pDNA complexes after lung administration. The efficiency is viewed as the product of the release of pDNA and the protection against DNase degradation as evaluated in the agarose gel retardation assay. Each curve corresponds to the same level of efficiency. Polyplex formulations that at the same time exhibit high release and high protection of pDNA, for example, DP15-21 polyplexes at charge ratio 60:1 (7), give the highest gene expression in vivo after lung administration.
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Chitosan polyplexes were prepared at pDNA concentrations of 5, 10 and 25 mg/ml in 1 ml sterile MilliQ water for use in in vivo studies. The polyplexes were concentrated in a SpeedVac Plus centrifuge (Savant Instruments, Holbrook, NY, USA) at 1400 rpm for approximately 90 min to obtain DNA concentrations of around 50, 100 and 250 mg/ml, respectively.
12 PEI (25 kDa) stock solutions (10 mM) and PEI polyplexes were prepared as described previously. 1 An optimal charge ratio of 5:1 (+/À) was used throughout.
2,12
Physicochemical characterization of chitosan polyplexes
The size of the polyplexes was determined by photon correlation spectroscopy (Zetasizer 4000, Malvern Instruments, Malvern, UK) and their zeta potentials (which indicate the surface charge) were determined by electrophoretic light scattering (Zetasizer 2000, Malvern Instruments). The physical stability of the complexes was studied using the agarose gel retardation assay (0.8% agarose in 40 mM TAE buffer, pH 8.5) as described previously. 12 In some agarose gel retardation experiments, indicated in the text, TAE buffer at pH 5.0 and 7.4 was used. The stability of the polyplexes was also studied in the gel retardation assay after incubating the polyplexes with 5 mg/ml heparin (Sigma, St Louise, MO, USA) for 2 h at room temperature. Protection of complexed pDNA against DNase degradation was studied after incubating polyplexes in the presence or absence of 1 U DNase I (Ambion, Austin, TX, USA) for 15 min as described previously. 45 After incubation, polyplexes were dissociated with heparin (5 mg/ml) and the integrity of pDNA was examined using the agarose gel retardation assay. pDNA obtained from the stock solution was used as control.
Morphological characterization of chitosan polyplexes
Chitosan polyplexes were imaged by tapping mode atomic force microscopy, employing a Digital Instrument Multimode IIIa equipped with an E scanner (maximum xy range B15 mm, Digital Instruments, Santa Barbara, CA, USA). Dried specimens of the samples to be imaged were prepared by deposition of a 10 ml aliquot of the aqueous solution of polyplexes on a freshly cleaved 5 mm diameter mica surface and incubated for 2 min. The samples were then dried with a stream of N 2 gas (P ¼ 1.5 bar), followed by vacuum drying (P ¼ 10 À9 bar) for at least 2 h. For the immobilization of uncomplexed DNA on mica, 0.5 mM ZnCl 2 was added to the solution immediately before transferring the solution to the mica. 46 Tapping mode silicon nitride cantilevers TESP (Digital Instruments), with nominal spring constants of 20-100 N/m and nominal resonant frequencies of 200-400 kHz, were used for the imaging. The drive frequency used was less than the free oscillation resonance frequency of the cantilever, yielding 90% of the amplitude at the resonance frequency. Topographs were obtained with scan sizes in the range 1.5-2.0 mm (data collection at 512 Â 512 pixels) and a scan speed of approximately 1.5 Hz. Quantitative information was extracted from the AFM topographs by image analysis. Based on the calculation of a shape factor for each polyplex structure, reflecting the symmetry of the structure about the three axis of rotation, the polyplexes were sorted into three different classes (toroidal, rod-like and spherical shapes). 47, 48 In vitro gene transfer Most in vitro transfection studies were performed in the epithelial human embryonic kidney cell line 293. The cells (45 000 cells/cm 2 ) were seeded at 70% confluence in 96-well tissue culture plates (Costar, Cambridge, UK) 24 h before transfection. For transfection studies performed at pH 7.4, serum-free medium (Optimem, Gibco/ BRL Life Technologies AB, Täby, Sweden) was added to polyplexes formulated in MilliQ water (having a final pH of around 5). For transfection studies performed at pH 5, acetate buffer (25 mM, pH 5) was used. 20 Isotonicity (300 mOsm/kg) was obtained by the addition of mannitol. The cells were washed in preheated Optimem and 50 ml of the complex formulations (corresponding to 0.33 mg pDNA) was added per well. After 5 h incubation, 12 The amount of luciferase expressed was determined from a standard curve prepared with firefly luciferase (Sigma, St Louis, MO, USA) and total cell protein was measured using the bichinchoninic acid test (Pierce, Rockford, IL, USA).
Intracellular dehydrogenase activity
The effect of polyplexes on intracellular dehydrogenase activity (a measure of cellular toxicity) in 293 cells was determined by the MTT method as described previously.
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Intratracheal administration to mouse lungs
The animal experiments were approved by The Swedish National Board for Laboratory Animals (the local ethical committee in Uppsala, Sweden). BALB/c mice aged 6-8 weeks were anaesthetized with ketamin/xylazine (5/ 20 vol%, 0.1 ml/10 g of body weight), and the trachea was surgically exposed by a 0.5 cm long skin incision in the neck. Polyplexes in a volume of 100 ml were slowly injected into the trachea with a 28 G needle in two 50 ml portions. The mice were killed (CO 2 ) 24, 48 and 72 h later, the lungs were removed, washed in ice-cold PBS, homogenized in a Beadbeater (Biospec Products, Bartlesville, OK, USA) for 1 min in ice-cold luciferase lysis buffer (Promega) with a protease inhibitor cocktail (Complete, Boehringer Mannheim Scandinavia AB, Bromma, Sweden), centrifuged at 15 000 rpm at 41C, mixed with luciferase reagent (Promega) and the luciferase gene expression was determined as described for the in vitro expression analysis above.
In order to determine the distribution of the luciferase gene expression in mouse lungs, lungs were removed, placed on ice and dissected into parenchyma, bronchial tree and trachea. A blunt scalpel was used to carefully scrape off the lung parenchyma, leaving a network of bronchi and bronchioles. Samples were then processed and assayed for luciferase gene expression as described above.
Histology
The lung histology was evaluated in blind observations for the appearance of inflammatory cells and structural damage as described previously. 50 Mice were killed 24 h after the intratracheal administration of polyplexes, and after cardiac perfusion with PBS and 3% paraformaldehyde in PBS, the lungs were removed, rinsed in PBS and stored overnight in 3% paraformaldehyde. The lungs were frozen the next day in OCT Embedding Medium (Sakura Finetek Europe, Zoeterwoude, The Netherlands). Cryosections (5 mm) were cut in a Leica Jung CM 3000 cryostat (Leica Instruments GmbH, Nussloch, Germany), stained briefly with haematoxylin and eosin, mounted and examined under a light microscope.
Statistics
The experiments were performed on a minimum of two occasions using quadruplicate samples each time. The gene expression is presented as the amount of the expressed transgene per mg (in vitro) or mg (in vivo) of tissue protein. All data are expressed as mean values71 standard deviation (s.d.). Statistical differences between mean values were investigated using ANOVA. Statistical differences between the physical shapes of the polyplexes were investigated using contingency tables analysis. Statistical differences are denoted as *Po0.05, **Po0.01 and ***Po0.001, respectively.
